Quest Diagnostics adds Timothy Wentworth, former Walgreens CEO, to its board of directors
Quest Diagnostics' board elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, as a director on March 9, 2026, and appointed him to its Compensation and Leadership Development Committee and Quality and Compliance Committee. The board board has eleven members including Mr. Wentworth, and it determined he is independent under NYSE standards. The filing does not report any financial results or guidance.
Key points
- Board election effective March 9, 2026; board now has eleven members
- Mr. Wentworth, 65, previously was CEO of Walgreens Boots Alliance, founding CEO of Evernorth Health Services and CEO of Express Scripts
- Received a prorated one-time restricted share unit grant valued at approximately $43,000
- Named to Compensation and Leadership Development Committee and Quality and Compliance Committee
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 12, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.